Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.42 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.42 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17055375 | 0.98 | RAB9A (0.53) | RAB9ANPC1USP2TP53PKM | |
| SCHEMBL17051575 | 0.87 | NPC1 (0.44) | RAB9ANPC1USP2TP53PKM | |
| SCHEMBL17055542 | 0.87 | LDHA (0.47) | RAB9ANPC1USP2TP53PKM | |
| SCHEMBL2493590 | 0.84 | RAB9A (0.62) | RAB9ANPC1USP2TP53PKM | |
| SCHEMBL17055379 | 0.84 | MAPT (0.45) | RAB9ANPC1USP2TP53PKM | |
| SCHEMBL24689621 | 0.83 | SMARCA2 (0.41) | RAB9ANPC1USP2TP53PKM | |
| SCHEMBL17055412 | 0.82 | NPC1 (0.53) | RAB9ANPC1USP2TP53PKM | |
| SCHEMBL10000239 | 0.81 | NPC1 (0.53) | RAB9ANPC1TP53PKMSMN1; SMN2 | |
| SCHEMBL29105358 | 0.81 | NPC1 (0.57) | RAB9ANPC1USP2TP53PKM | |
| SCHEMBL30661709 | 0.81 | NPC1 (0.57) | RAB9ANPC1USP2TP53PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240246937-A1 | IL4I1 INHIBITORS AND METHODS OF USE | MERCK SHARP & DOHME LLC (US) | 2024-07-25 | — | — | US | disclosed |
| EP-4329889-A1 | IL4I1 INHIBITORS AND METHODS OF USE | Merck Sharp & Dohme LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| EP-4242205-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| EP-4243101-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023136457-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-07-20 | — | — | WO | disclosed |
| US-20230183279-A1 | ORGANOMETALLIC COMPLEX, LIGHT EMITTING DIODE, AND ELECTRONIC DEVICE | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20230183279-A1 | ORGANOMETALLIC COMPLEX, LIGHT EMITTING DIODE, AND ELECTRONIC DEVICE | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-06-15 | — | — | US | disclosed |
| US-11653564-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-05-16 | — | — | US | disclosed |
| US-11653564-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-05-16 | — | — | US | disclosed |
| US-20230052191-A1 | NOVEL COMPOUNDS | MISSION THERAPEUTICS LTD (GB) | 2023-02-16 | — | — | US | disclosed |
| US-7348327-B2 | Compounds | SANOFI-AVENTIS (FR) | 2008-03-25 | — | — | US | disclosed |
| US-7348327-B2 | Compounds | SANOFI-AVENTIS (FR) | 2008-03-25 | — | — | US | disclosed |
| WO-2008011176-A9 | MYOSIN LIGHT CHAIN KINASE INHIBITOR COMPOUNDS, COMPOSITIONS AND RELATED METHODS OF USE | UNIV NORTHWESTERN (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008011176-A2 | MYOSIN LIGHT CHAIN KINASE INHIBITOR COMPOUNDS, COMPOSITIONS AND RELATED METHODS OF USE | NORTHWESTERN UNIVERSITY (US) | 2008-01-24 | — | — | WO | disclosed |
| US-20080021035-A1 | Myosin light chain kinase inhibitor compounds, compostions and related methods of use | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-01-24 | — | — | US | disclosed |
| US-20080021035-A1 | Myosin light chain kinase inhibitor compounds, compostions and related methods of use | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-01-24 | — | — | US | disclosed |
| US-20070142350-A1 | THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL- AND PIPERAZINYL-ALKYL CARBAMATES | SANOFI-AVENTIS (FR) | 2007-06-21 | — | — | US | disclosed |
| US-20070142350-A1 | THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL- AND PIPERAZINYL-ALKYL CARBAMATES | SANOFI-AVENTIS (FR) | 2007-06-21 | — | — | US | disclosed |
| US-7214798-B2 | Derivatives of piperidinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics | SANOFI-AVENTIS (FR) | 2007-05-08 | — | — | US | disclosed |
| US-7214798-B2 | Derivatives of piperidinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics | SANOFI-AVENTIS (FR) | 2007-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021035-A1 | Myosin light chain kinase inhibitor compounds, compostions and related methods of use | MYLK, MYLK3, MYLK2 | RAB9A 3811/4885NPC1 4879/4885USP2 1574/4885 |
| US-11653564-B2 | Compound and organic light-emitting device comprising same | CRY1, CYP1A1, TMEM109 | RAB9A 2906/4885NPC1 1165/4885USP2 3599/4885 |
| US-20230183279-A1 | ORGANOMETALLIC COMPLEX, LIGHT EMITTING DIODE, AND ELECTRONIC DEVICE | NR2E3, CRY1, GRK1 | RAB9A 2685/4885NPC1 4328/4885USP2 2914/4885 |
| US-20070142350-A1 | THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL- AND PIPERAZINYL-ALKYL CARBAMATES | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, H1-2 | RAB9A 3503/4885NPC1 339/4885USP2 1899/4885 |
| US-20230052191-A1 | NOVEL COMPOUNDS | UCHL1, UCHL3, UCHL5 | RAB9A 480/4885NPC1 2546/4885USP2 14/4885 |
| US-20240246937-A1 | IL4I1 INHIBITORS AND METHODS OF USE | IL4I1, IL4, IL2 | RAB9A 3769/4885NPC1 2807/4885USP2 2838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.